Runner in blue activewear on a country road at sunrise, with decorative red and blue light trails.

Can Your Lactate Levels Warn You Before Blood Sugar Does?

A source guide to resting-lactate research and the questions a test can answer.

The cited studies do not establish a personal early-warning test beyond standard glucose testing. They report associations under different conditions.

Read the population, adjustment and measured outcome together before treating a research signal as a useful screening decision.

Image context: The runner and decorative light trails do not depict a lactate measurement, a study participant, fuel switching or diabetes risk.

What Would an Earlier Warning Need to Show?

Ask whether the study measured a later diagnosis, a current laboratory association or a short experimental response. Then ask whether it assessed added prediction or a clinical decision beyond existing tests.

Keep Settings and Outcomes Separate

Source Question measured
2013 ARIC case-cohort Resting lactate and later incident diabetes, with adjusted models.
Separate 2013 ARIC cohort Resting lactate and later self-reported diabetes.
2024 study Baseline associations and responses around short feeding, not incident diabetes.
CDC diabetes-testing guidance Established A1C and glucose-based assessment contexts.

Two ARIC Analyses, Two Adjusted Results

In the 2013 ARIC case-cohort analysis, 544 incident diabetes cases were compared with 533 non-cases. The lactate association became nonsignificant after fasting glucose and insulin were added to the main model.

A separate 2013 analysis followed 8,045 people for a median of 12 years. A smaller association remained after adjustment for fasting glucose and insulin, but later diabetes was self-reported.

These adjusted findings differ. Neither analysis established a diagnostic cutoff or showed that lactate outperformed standard glucose tests.

Baseline Associations and Short Feeding Responses

The 2024 abstract describes 50 participants classified as overweight. Baseline fasting lactate related to HOMA-IR, an insulin-resistance estimate, triglycerides and blood pressure.

It also describes before-and-after measurements around three-day energy-balanced high-fat feeding, with sex-specific changes. Baseline correlations and short feeding responses are different outcomes from later incident diabetes.

These research conditions are not a diet recommendation, a sex-specific plan or a personal screening cutoff.

What Standard Diabetes Testing Addresses

The CDC page describes A1C, fasting glucose and glucose-tolerance testing in their different measurement contexts. It does not list lactate as a diabetes-screening test.

Ask a clinician which test addresses the clinical question and how its result should be interpreted. This guide supplies no diagnostic range, screening schedule or medication instruction.

Different Clinical Questions

Cleveland Clinic’s lactic-acidosis guide discusses clinical assessment and treatment of underlying causes. That is a different clinical question from an observational association with later diabetes.

What This Evidence Does Not Prove

An association does not establish that a high lactate result causes diabetes. These studies do not supply a validated home-testing protocol or an individual prediction threshold.

Common Interpretation Mistakes

  • Combining two analyses because both use the ARIC name.
  • Treating a baseline correlation as a later-disease outcome.
  • Reading an adjusted association as an individual diagnosis.
  • Using a video title or a consumer reading as evidence that a clinical decision was validated.

A Source and Clinical-Question Record

Write down the source and date, population and setting, outcome and comparison, and what the result would actually change. Keep an unanswered question visible instead of filling it with a personal-risk estimate.

Discussion prompt: Which clinical question would this proposed test answer, and would it add information that changes care? This is a question record, not a self-testing or diagnosis algorithm.

Source and Video Scope

This article uses the cited research and clinical pages. It does not assess unreviewed presenter statements or provide a video transcript.

References

Juraschek, S. P., et al. (2013). Lactate and risk of incident diabetes in a case-cohort of the Atherosclerosis Risk in Communities (ARIC) Study. PLOS ONE, 8(1), e55113. Primary record.

Juraschek, S. P., et al. (2013). Plasma lactate and diabetes risk in 8045 participants of the Atherosclerosis Risk in Communities Study. Annals of Epidemiology, 23(12), 791 to 796.e4. Primary record.

[Fasting-lactate and short-feeding study]. (2024). Primary abstract, DOI 10.1016/j.dsx.2024.102955.

CDC. (2024). Diabetes testing.

Cleveland Clinic. (2023). Lactic acidosis.

The 2024 summary uses the primary abstract; the ARIC distinctions use the earlier checked primary records. This article does not claim a fresh reading of the unavailable full papers.

The bracketed study label is a descriptive locator, not an asserted publication title.

This article is health education, not personal medical advice. Ask a qualified clinician to interpret testing or symptoms in your circumstances.

Share your love
Chris Pruitt, certified personal trainer and WorkoutHealthy founder
Chris Pruitt

Chris Pruitt is a certified ASFA personal trainer and the founder of WorkoutHealthy, a fitness equipment retailer serving customers since 2007. He has more than 16 years in the fitness business, and he writes and fact checks everything published on Insider.

The Insider Five

Five stories worth your time, every Friday. One email a week, no pitches.